
NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine
Notas do episódio
November 12, 2026; 6pm: Jim Cramer weighs what a Jensen-less NVIDIA could mean for shareholders, breaks down Kraft Heinz’s turnaround pitch and Anthropic’s IPO setup, and interviews Moderna CEO Stéphane Bancel about the company’s cancer vaccine pipeline.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.